If you made any changes in Pure these will be visible here soon.

Research Outputs 2009 2019

  • 495 Citations
  • 12 h-Index
  • 22 Article
  • 2 Meeting abstract
  • 2 Letter
  • 1 Review article
Meeting abstract

The MAPK-activated protein kinase 2 (MK2) inhibitor CMPD1 is a novel microtubule targeting agent for glioblastoma therapy

Gurgis, F., Åkerfeldt, M., Wong, C., Heng, B., Guillemin, G. J., Chircop, M. & Munoz, L., Aug 2015, In : Clinical Therapeutics. 37, 8 Supplement, p. e114 1 p.

Research output: Contribution to journalMeeting abstractResearchpeer-review


The p38-mk2-hur pathway potentiates egfrviii-il-1 beta-driven il-6 secretion in glioblastoma cells

Gurgis, F., Yeung, Y. T., Tang, M., Heng, B., Buckland, M., Ammit, A. J., Haapasalo, J., Haapasalo, H., Guillemin, G. J., Grewal, T. & Munoz, L., Nov 2014, In : Asia-Pacific Journal of Clinical Oncology. 10, p. 45-45 1 p.

Research output: Contribution to journalMeeting abstractResearch